The Treatment Planning Systems and Advanced Image Processing Market was valued at USD 2.68 billion in 2024 and is projected to grow from USD 2.9 billion in 2025 to reach USD 5.45 billion by 2033, expanding at a CAGR of 8.18% during the forecast period (2025–2033). This growth is driven by the rising global incidence of cancer, technological advancements in healthcare IT, and increased demand for precision oncology solutions.

? Download Sample Report

Market Overview

Treatment planning systems (TPS) are advanced software programs designed to optimize radiation therapy for cancer patients by maximizing tumor radiation while minimizing exposure to surrounding healthy tissues. Complementing this, advanced image processing involves sophisticated algorithms applied to medical imaging data such as MRIs, CT scans, PET scans, and X-rays, playing a pivotal role in accurate diagnosis, treatment planning, and medical research.

With nearly half of all cancer patients undergoing radiotherapy, the demand for innovative treatment planning software and advanced image processing solutions is increasing. Rising investments in healthcare IT infrastructure and government initiatives worldwide are also strengthening market momentum.

Market Drivers

Rising Mortalities Due to Cancer

Cancer remains one of the leading causes of death globally, making the development of advanced treatment solutions essential. The expanding use of radiotherapy, which already treats nearly 50% of cancer patients, is fueling adoption of treatment planning systems and advanced imaging software. The U.S. alone has 2,332 radiotherapy centers, with global survivors expected to surpass 4.1 million by 2030, further driving demand for precise planning solutions.

Growing Popularity of Radiotherapy

Radiotherapy is increasingly being chosen for its efficacy in cancer treatment. For instance, nearly 49% of early-stage breast cancer patients in the U.S. undergo breast-conserving surgery followed by radiation therapy. Countries like Mexico are also upgrading healthcare infrastructure, with Elekta recently receiving government approval to supply advanced radiotherapy equipment to the Instituto Mexicano del Seguro Social (IMSS).

Emerging Opportunities in Artificial Intelligence

Artificial intelligence and machine learning are revolutionizing oncology by enabling automated diagnosis, adaptive treatment planning, and predictive analytics. Projects like CancerLinQ in the U.S., which compiles over 1.4 million patient records, and the AI-LAB initiative by the American College of Radiology Data Science Institute are accelerating the integration of AI in cancer care, opening new opportunities for market players.

Market Restraints

Despite rapid adoption in developed regions, high software costs, limited adoption in developing countries, and a shortage of skilled professionals to operate advanced systems remain major barriers. These factors hinder widespread market penetration, particularly in cost-sensitive regions.

Regional Insights

In 2023, North America accounted for 40.5% of the global revenue, thanks to its advanced healthcare infrastructure, research institutions, and rapid adoption of healthcare IT. Meanwhile, the Asia-Pacific region is projected to witness the fastest CAGR during the forecast period due to rising cancer incidences and healthcare investments in countries such as India and China. Globocan estimates that the region will record over 9.5 million new cancer cases, creating substantial demand for advanced oncology solutions.

Component and Technique Insights

  • Treatment Planning Software dominated the market with 88.1% share in 2023, led by auto-contouring software, which held 32.1% share. The shift from manual to automated contouring has improved precision and efficiency in radiotherapy.

  • Image Registration using Graphics Processor Units generated 27.4% of revenue in 2021, highlighting the growing significance of real-time image dataset creation for accurate dosage planning.

End-User Insights

Hospitals remain the largest end users, as they are central to cancer treatment delivery. However, cancer research institutes are expected to grow at the fastest rate, given their focus on clinical trials, drug development, and adoption of cutting-edge technologies.

Key Players

The competitive landscape is shaped by leading companies focusing on innovation, AI integration, and global partnerships. Major players include:

  • Varian Medical Systems Inc.

  • Elekta

  • RaySearch Laboratories

  • MIM Software Inc.

  • Brainlab AG

  • Accuray Incorporated

  • ViewRay Technologies Inc.

  • DOSIsoft SA

  • Koninklijke Philips N.V.

  • IBA

Dental and medical device players such as Institut Straumann AG, Nobel Biocare, and Dentsply Sirona also contribute through specialized imaging and planning solutions.

Recent Developments

  • Fujitsu partnered with the University of Toronto (2021) to streamline radiation treatment plans.

  • Mirada Medical launched its online auto-contouring software DLCExpert during the COVID-19 pandemic.

  • OncoLens raised USD 7.3 million in Series A funding (2021) to advance oncology collaboration platforms.

  • Accuray and Brainlab collaborated to enhance the CyberKnife platform for neuro-radiosurgery.

  • ViewRay Inc. partnered with VieCure to promote personalized cancer care.

These collaborations emphasize the industry’s focus on AI-driven, patient-centered oncology solutions.

Conclusion

The treatment planning systems and advanced image processing market is set for robust growth, reaching USD 5.45 billion by 2033. Rising cancer incidences, advancements in AI and machine learning, and the global expansion of radiotherapy infrastructure are the primary growth drivers. While high costs and limited adoption in developing nations remain challenges, growing investments and technological innovation promise significant opportunities for key players and healthcare providers worldwide.

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision-making and ROI.

Whether you are looking at business sectors in the next town or across continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

? Phone: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
? Email: sales@straitsresearch.com